Position in AZN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$53,536,741
+$3,618,191 QoQ
Shares Held
282,337
+11.5% QoQ
Ownership
0.018%
of shares outstanding
% of Portfolio
0.11%
of 13F equity value
Holder Rank
#156
of 1,459 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 85%
Shared 0%
None 15%
Common Shares in AZN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Thrivent Financial for Lutherans holds $1,673,064,906 across 14 Drug Manufacturers - General names. AZN ranks #8 (3.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
396,540 | $475,622,010 | |
| 2 | JNJ |
Johnson & Johnson
|
1,458,722 | $370,471,625 | |
| 3 | MRK |
Merck & Co., Inc.
|
2,340,397 | $300,741,013 | |
| 4 | AMGN |
Amgen Inc
|
494,025 | $178,896,331 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
876,893 | $110,786,660 | |
| 6 | ABBV |
AbbVie Inc.
|
391,576 | $98,536,182 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
1,147,117 | $66,096,880 | |
| 8 | AZN |
Astrazeneca PLC
This page
|
282,337 | $53,536,741 |
All Filings in AZN
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $53,536,741 | 282,337 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $49,918,550 | 253,111 | Shares | Sole | 2026-05-01 | |
| No filing history on record for this holder in this stock. | ||||||